by Citizen Wells
Guillain Barre Syndrome GBS warning added to Johnson & Johnson Covid19 vaccine by FDA, Chances of getting 3 to 5 times higher after vaccination
“two papers published May 19 in the journal of Hospital Pediatrics found pediatric hospitalizations for COVID were over counted by at least 40%, carrying potential implications for nationwide figures used to justify vaccinating children.”...The Defender
“it is universally known that children virtually never die from COVID-19 and given that children have a very strong immune system, they are more likely than adults to have an over-reaction to the shot.”…Dr. Steven Roth
“There is not yet enough evidence on the use of vaccines against COVID-19 in children to make recommendations for children to be vaccinated against COVID-19. Children and adolescents tend to have milder disease compared to adults. However, children should continue to have the recommended childhood vaccines.”…WHO
From The Defender July 12, 2021.
“FDA to Add Warning to J&J Vaccine of ‘Serious But Rare’ Autoimmune Disorder
The U.S. Food and Drug Administration will announce a new warning on Johnson & Johnson’s COVID vaccine saying the shot is linked to Guillain–Barré syndrome. In April, the agency added a warning about blood clotting disorders to the J&J shot.
According to The New York Times, the chances of developing GBS after receiving the J&J shot is three to five times higher than would be expected in the general population in the U.S.
About 100 preliminary reports in
the U.S. of GBS have been detected after receiving J&J’s vaccine,
the Centers for Disease Control and Prevention (CDC) said in a statement to CNN today. Most cases were reported about two weeks after vaccination, mostly in men 50 and older.